Navigation Links
CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium

ATLANTA, Oct. 18 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that it will conduct its annual Cardiac Surgery Fellows Allograft Symposium on October 19, 2007, at the Company's corporate headquarters training facility in Kennesaw, Ga. The program will include discussions and demonstrations of surgical techniques of aortic valve replacement and thoracoabdominal aortic aneurysm repair, as well as provide a practical laboratory in which to demonstrate and practice the techniques for proper implant site preparation and allograft implantation.

The keynote speaker will be David C. McGiffin, M.D., Associate Director, Division of Cardiothoracic Surgery and Chief, Section of Cardiopulmonary Transplantation at the University of Alabama, Birmingham, Ala. The program will be attended by 27 surgery fellows from major U.S. surgical training institutions, and will be directed by Paul E. Stelzer, M.D., Senior Faculty, Cardiothoracic Surgery, Mount Sinai School of Medicine, New York, N.Y.

Three additional distinguished cardiovascular surgeons complete the faculty of this program: John W. Fehrenbacher, M.D., Department of Cardiothoracic Surgery, CORVASC, Indianapolis, Ind; Francis Robicsek, M.D., Ph.D., Chairman, Department of Thoracic and Cardiovascular Surgery, Carolinas Medical Center, Charlotte, N.C.; and Craig R. Saunders, M.D., Chairman, Cardiothoracic Surgery, Saint Barnabas Health Care System, Newark, N.J.

"The Cardiac Surgery Fellows Allograft Symposium creates a unique atmosphere in which to engage in thought provoking discussions about complex surgical procedures with leading cardiovascular surgeons in the field," said Dr. Stelzer. "The additional opportunity to practice allograft implantation techniques in a wet lab environment offers an invaluable educational opportunity for these cardiac fellows."

About CryoLife, Inc.

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve and the SG Model 100 vascular graft, which are CE marked for distribution within the European Community.

For additional information about the company, visit CryoLife's Web site:

Media Contacts:

D. Ashley Lee

Executive Vice President, Chief Operating Officer and

Chief Financial Officer

CryoLife, Inc.

Phone: 770-419-3355

Katie Brazel


Phone: 404-739-0150

SOURCE CryoLife, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Study explains unexpected conductivity of nanoscale silicon
2. Engineers chart semiconductors on the scale of atoms
3. NameProtect releases annual list of top trademarkers
4. Doyle says new contracts saving state more than $16 million annually
5. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
6. Annual Bioethics Forum to explore genetic testing
7. Annual Conference Honors Tech Grant Winners
8. Criticare gets OK to market portable cardiac monitor
9. Software to aid brain surgery is goal of Milwaukee startup
10. UW-Madison has 7 Sloan research fellows, top in nation
11. Symposium will include venture capital "coaching"
Post Your Comments:
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division of ... and optimized exclusively for Okuma CNC machining centers at The International Manufacturing Technology ... among several companies with expertise in toolholding, cutting tools, machining dynamics and distribution, ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):